European shares gain on earnings boost; Novo Nordisk slips

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

Switzerland Nachrichten Nachrichten

Switzerland Neuesten Nachrichten,Switzerland Schlagzeilen

European shares gain on earnings boost; Novo Nordisk slips

- European shares opened higher on Wednesday, as a slew of upbeat corporate earnings lifted sentiment, although gains were capped after heavyweight Novo Nordisk (NYSE:Novo Nordisk dropped 6.6% after the obesity drugmaker posted quarterly operating profit below expectations and also cut its annual profit outlook.

Among other notable moves, car parts maker Continental jumped 5% after it trounced expectations for second-quarter results.Beiersdorf slipped nearly 4% despite the Nivea maker reporting a 7.1% organic sales growth for the first half of the year.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 450. in CH
 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Herkunft: NBCLA - 🏆 319. / 59 Weiterlesen »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »

Lilly, Novo Nordisk Battle for Weight-loss Market Lands At the Pharmacy ShelfAs Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is...
Herkunft: Medscape - 🏆 386. / 55 Weiterlesen »